{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:31:06Z","timestamp":1786991466090,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.japh.2023.06.027","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T03:53:16Z","timestamp":1688442796000},"page":"1700-1705.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cost minimization analysis of short-duration antiviral prophylaxis for hepatitis C positive donor kidney transplants"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3894-0503","authenticated-orcid":false,"given":"Jessica S.","family":"Jay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Ijioma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7134-2372","authenticated-orcid":false,"given":"Norman V.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7661-9326","authenticated-orcid":false,"given":"David A.","family":"Holdford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8637-2475","authenticated-orcid":false,"given":"Richard K.","family":"Sterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7871-3479","authenticated-orcid":false,"given":"Idris","family":"Yakubu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.japh.2023.06.027_bib1","doi-asserted-by":"crossref","first-page":"702","DOI":"10.7326\/M17-2451","article-title":"The drug overdose epidemic and deceased-donor transplantation in the United States a national registry study","volume":"168","author":"Durand","year":"2018","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.japh.2023.06.027_bib2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJMp1505074","article-title":"Transplanting hepatitis C\u2013positive kidneys","volume":"373","author":"Reese","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.japh.2023.06.027_bib3","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/j.1600-6143.2010.03091.x","article-title":"Underutilization of hepatitis C-positive kidneys for hepatitis c-positive recipients","volume":"10","author":"Kucirka","year":"2010","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.japh.2023.06.027_bib4","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s11606-018-4477-8","article-title":"Impact of drug overdose deaths on solid organ transplantation in the United States","volume":"33","author":"Cholankeril","year":"2018","journal-title":"J\u00a0Gen Intern Med"},{"issue":"1","key":"10.1016\/j.japh.2023.06.027_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M20-1468","article-title":"Four-week direct-acting antiviral prophylaxis for kidney transplantation from hepatitis C-viremic donors to hepatitis C-negative recipients: an open-label nonrandomized study","volume":"174","author":"Durand","year":"2021","journal-title":"Ann Intern Med"},{"issue":"24","key":"10.1016\/j.japh.2023.06.027_bib6","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1056\/NEJMc1705221","article-title":"Trial of transplantation of HCV-infected kidneys into uninfected recipients","volume":"376","author":"Goldberg","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.japh.2023.06.027_bib7","doi-asserted-by":"crossref","first-page":"523","DOI":"10.7326\/M17-2871","article-title":"Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis C virus-infected donors to noninfected recipients an open-label nonrandomized trial","volume":"168","author":"Durand","year":"2018","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.japh.2023.06.027_bib8","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/tri.13410","article-title":"Renal transplantation from seropositive hepatitis C virus donors to seronegative recipients in Spain: a prospective study","volume":"32","author":"Franco","year":"2019","journal-title":"Transpl Int"},{"issue":"11","key":"10.1016\/j.japh.2023.06.027_bib9","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1681\/ASN.2020050686","article-title":"Multicenter study to transplant hepatitis C-infected kidneys (mythic): an open-label study of combined glecaprevir and pibrentasvir to treat recipients of transplanted kidneys from deceased donors with hepatitis c virus infection","volume":"31","author":"Sise","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"17","key":"10.1016\/j.japh.2023.06.027_bib10","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJMoa1812406","article-title":"Heart and Lung transplants from HCV-infected donors to uninfected recipients","volume":"380","author":"Woolley","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.japh.2023.06.027_bib11","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/ajt.15583","article-title":"Fibrosing cholestatic hepatitis after kidney transplantation from HCV-viremic donors to HCV-negative recipients: a unique complication in the DAA era","volume":"20","author":"Kapila","year":"2020","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.japh.2023.06.027_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.31011","article-title":"Hepatitis C virus NAT-positive Solid organ allografts transplanted into hepatitis C virus\u2013negative recipients: a real-world experience","volume":"72","author":"Kapila","year":"2020","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.japh.2023.06.027_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofy076","article-title":"Absolute insurer denial of direct-acting antiviral therapy for hepatitis C: a national specialty pharmacy cohort study","volume":"5","author":"Gowda","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.japh.2023.06.027_bib14","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.jhep.2018.06.016","article-title":"The removal of DAA restrictions in Europe \u2013 one step closer to eliminating HCV as a major public health threat","volume":"69","author":"Marshall","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"20","key":"10.1016\/j.japh.2023.06.027_bib15","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","article-title":"Sofosbuvir for previously Untreated chronic hepatitis C infection","volume":"368","author":"Lawitz","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.japh.2023.06.027_bib16","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/ajt.15664","article-title":"Ultra-short duration direct acting antiviral prophylaxis to prevent virus transmission from hepatitis C viremic donors to hepatitis C negative kidney transplant recipients","volume":"20","author":"Gupta","year":"2020","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.japh.2023.06.027_bib17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S2468-1253(20)30081-9","article-title":"Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study","volume":"5","author":"Feld","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.japh.2023.06.027_bib18","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1111\/ajt.16747","article-title":"Outcomes of short-duration anti-viral prophylaxis for hepatitis C positive donor kidney transplants","volume":"21","author":"Gupta","year":"2021","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.japh.2023.06.027_bib19","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/ajt.15054","article-title":"Cost-effectiveness of hepatitis C\u2013positive donor kidney transplantation for hepatitis C\u2013negative recipients with concomitant direct-acting antiviral therapy","volume":"18","author":"Gupta","year":"2018","journal-title":"Am J Transplant"},{"issue":"24","key":"10.1016\/j.japh.2023.06.027_bib20","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1056\/NEJMc1705221","article-title":"Trial of transplantation of HCV-infected kidneys into uninfected recipients","volume":"376","author":"Goldberg","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.japh.2023.06.027_bib21","author":"Draper"},{"issue":"11","key":"10.1016\/j.japh.2023.06.027_bib24","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1111\/ajt.15530","article-title":"Transplantation of kidneys from hepatitis C\u2013infected donors to hepatitis C\u2013negative recipients: single center experience","volume":"19","author":"Molnar","year":"2019","journal-title":"Am J Transplant"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319123002406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319123002406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:53:09Z","timestamp":1761544389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319123002406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1544319123002406"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2023.06.027","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost minimization analysis of short-duration antiviral prophylaxis for hepatitis C positive donor kidney transplants","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2023.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Pharmacists Association\u00a9. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}